Plug Power Inc (NASDAQ:PLUG), in a corporate blog post, noted that its sales team attended the Green Retail Decisions Innovation Summit from June 2-4, where sales executives Chris Tully and Fernando Corral held face-to-face meetings with executives from companies including Walgreens (WAG), Price Chopper and Family Dollar (FDO). “These decision-makers from a wide range of organizations showed interested in replacing the lead-acid batteries in their distribution warehouse forklift fleets with efficient, zero emission hydrogen fuel cells,” according to Plug. Plug Power Inc (NASDAQ:PLUG) weekly performance is -7.43%. On last trading day company shares ended up $4.11. Analysts mean target price for the company is $4.88. Plug Power Inc (NASDAQ:PLUG) distance from 50-day simple moving average (SMA50) is -21.37%.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)announced the pricing of $200 million aggregate principal amount of its 3.625% convertible senior notes due 2019 (the “Notes”) in a private placement. The Notes will be offered by the initial purchasers only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). ARIAD also granted the initial purchasers of the Notes an option, exercisable for 30 days, to purchase up to an additional $30 million aggregate principal amount of the Notes on the same terms and conditions. As a result of the convertible note hedge and warrant transactions described below, the effective conversion price for the Notes is expected to be $12.00 per share, which represents a 71% premium over the closing price of ARIAD’s common stock of $7.02 per share on June 11, 2014. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares fell -8.69% in last trading session and ended the day on $6.41. ARIA return on assets is -66.50%. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) quarterly performance is -14.65%.
On June 2, 2014, Galena Biopharma Inc (NASDAQ:GALE) announced that data from the Company’s Phase 1 study with GALE-301, or Folate Binding Protein (FBP), was presented at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting. The poster entitled, “Comparison of recurrent and nonrecurrent ovarian and uterine cancer patients undergoing adjuvant folate receptor vaccine therapy,” was presented during the Gynecologic Cancer General Poster Session. Galena Biopharma Inc (NASDAQ:GALE) shares moved down -4.62% in last trading session and was closed at $3.10, while trading in range of $3.09 – $3.38. Galena Biopharma Inc (NASDAQ:GALE) year to date (YTD) performance is -37.50%.
O June2, British Airways parent IAMGOLD Corp (USA) (NYSE:IAG) plans to buy new aircraft for its Iberia arm after the Spanish unit cut losses, according to Chief Executive Officer Willie Walsh, who had made fleet renewal contingent on improved earnings. IAMGOLD Corp (USA) (NYSE:IAG) ended the last trading day at $4.05. Company weekly volatility is calculated as 3.80%and price to cash ratio as 6.08. IAMGOLD Corp (USA) (NYSE:IAG) showed a positive weekly performance of 13.45%.
Arena Pharmaceuticals (NASDAQ:ARNA) saw a large decline in short interest in May. As of May 15th, there was short interest totalling 46,073,021 shares, a decline of 9.0% from the April 30th total of 50,611,732 shares, Stock Ratings Network reports. Approximately 21.2% of the company’s shares are sold short. Based on an average trading volume of 7,053,411 shares, the days-to-cover ratio is presently 6.5 days. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares moved up 3.72% in last trading session and was closed at $6.41, while trading in range of $6.31 – $6.45. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) year to date (YTD) performance is 9.57%.